A Study of the Use of PROCRIT (Epoetin Alfa) for the Treatment of Anemia in People With Chronic Kidney Disease Who Live in Long-term Care Facilities.
Clinical trial NCT00337935 · COMPLETED
Trial details
- NCT number
- NCT00337935
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Primary completion
- 2009-07-01
- Enrollment
- 157
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.